Lead
Indications
Research
5-HT
2C
agonists
BMB-101
DEE
Absence seizures
Clinical Studies - Phase 2
BMB-101
Prader-Willi Syndrome
Clinical Studies – Phase 2
BMB-105
Prader-Willi Syndrome
Clinical development
5-HT
2A/2C
agonists
BMB-201
Depression,Pain, Headache
Preclinical studies
5-HT
2A
agonists for the treatment of depression
BMB-202
Depression
(Fast-onset)
Preclinical studies